Singapore markets closed

AbbVie Inc. (ABBV)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
150.00-0.57 (-0.38%)
At close: 04:03PM EDT
150.00 0.00 (0.00%)
After hours: 07:50PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 266.85B
Enterprise value 332.75B
Trailing P/E 21.67
Forward P/E 10.71
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)4.73
Price/book (mrq)16.39
Enterprise value/revenue 5.87
Enterprise value/EBITDA 13.45

Trading information

Stock price history

Beta (5Y monthly) 0.81
52-week change 333.01%
S&P500 52-week change 3-3.48%
52-week high 3175.91
52-week low 3105.56
50-day moving average 3157.45
200-day moving average 3133.04

Share statistics

Avg vol (3-month) 37.38M
Avg vol (10-day) 36.32M
Shares outstanding 51.77B
Implied shares outstanding 6N/A
Float 81.77B
% held by insiders 10.11%
% held by institutions 170.83%
Shares short (12 May 2022) 414.23M
Short ratio (12 May 2022) 41.68
Short % of float (12 May 2022) 40.81%
Short % of shares outstanding (12 May 2022) 40.81%
Shares short (prior month 13 Apr 2022) 412.07M

Dividends & splits

Forward annual dividend rate 45.64
Forward annual dividend yield 43.75%
Trailing annual dividend rate 35.42
Trailing annual dividend yield 33.60%
5-year average dividend yield 44.27
Payout ratio 476.18%
Dividend date 315 May 2022
Ex-dividend date 413 Apr 2022
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 22.00%
Operating margin (ttm)35.41%

Management effectiveness

Return on assets (ttm)8.55%
Return on equity (ttm)83.12%

Income statement

Revenue (ttm)56.73B
Revenue per share (ttm)32.04
Quarterly revenue growth (yoy)4.10%
Gross profit (ttm)38.88B
Net income avi to common (ttm)12.41B
Diluted EPS (ttm)6.97
Quarterly earnings growth (yoy)26.40%

Balance sheet

Total cash (mrq)7.57B
Total cash per share (mrq)4.28
Total debt (mrq)73.65B
Total debt/equity (mrq)451.44
Current ratio (mrq)0.81
Book value per share (mrq)9.22

Cash flow statement

Operating cash flow (ttm)22.81B
Levered free cash flow (ttm)19.24B